Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Oncogene|October 7, 2023
The ASH1L-AS1-ASH1L axis controls NME1-mediated activation of the RAS signaling in gastric cancerMengyu Xie, Long Zhang, Linyu Han, et al.Molecular Cancer|February 25, 2025
Role of circular RNAs in cancer therapy resistanceWenjuan Liu, Jiling Niu, Yanfei Huo, et al.Life Sciences|February 24, 2022
The RNA editing enzyme ADAR modulated by the rs1127317 genetic variant diminishes EGFR-TKIs efficiency in advanced lung adenocarcinomaHui Hua, Jiajia Zeng, Haixin Xing, et al.Frontiers in Cell and Developmental Biology|July 5, 2023
New insights on the interplays between m<sup>6</sup>A modifications and microRNA or lncRNA in gastrointestinal cancersTao Su, Jiandong Liu, Nasha Zhang, et al.Journal of Experimental & Clinical Cancer Research : CR|April 19, 2023
LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilizationNasha Zhang, Bowen Wang, Chi Ma, et al.Archives of Toxicology|January 8, 2024
Genome-wide functional integration identified MAZ-controlled RPS14 dysregulation in hepatocellular carcinomaLinyu Han, Yanfei Huo, Linying Huang, et al.Archives of Biochemistry and Biophysics|August 7, 2025
Oncogenic RBM19 modulated by MAX-mediated allelic transcription regulation in hepatocellular carcinoma progressionYanxiu Zheng, Xiaolei Yin, Linyu Han, et al.Pharmacogenomics and Personalized Medicine|March 27, 2023
The Allelic Expression of RNA Editing Gene <i>ADARB1</i> in Hepatocellular Carcinoma Treated with Transarterial ChemoembolizationJiajia Zeng, Linyu Han, Teng Wang, et al.Plos One|January 13, 2017
Evaluation of Bufadienolides as the Main Antitumor Components in Cinobufacin Injection for Liver and Gastric Cancer TherapyXiaolu Wei, Nan Si, Yuefei Zhang, et al.Cancer Letters|August 28, 2024
MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activationJiajia Zeng, Long Zhang, Linying Huang, et al.Pageof 3